1. Home
  2. CGON
  3. CGON News

Latest CG ONCOLOGY INC (CGON) News on May 9, 2025

CGON

MT Newswires

7 days ago

JPMorgan Initiates Coverage on CG Oncology With Overweight Rating, $41 Price Target

Biotech Alert: Searches spiking for these stocks today
CGON

TipRanks

8 days ago

Biotech Alert: Searches spiking for these stocks today

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
CGON

Zacks

8 days ago

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
CGON

GlobeNewswire

8 days ago

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?
CGON

Zacks

10 days ago

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?

CGON

MT Newswires

10 days ago

RBC Raises Price Target on CG Oncology to $68 From $66, Keeps Outperform, Speculative Risk

Why CG Oncology, Inc. (CGON) Surged on Monday
CGON

Insider Monkey

10 days ago

Why CG Oncology, Inc. (CGON) Surged on Monday

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug
CGON

Investor's Business Daily

11 days ago

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug

CGON

MT Newswires

11 days ago

Top Midday Gainers

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
CGON

Benzinga

11 days ago

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why

CGON

MT Newswires

11 days ago

CG Oncology Reports Durable Responses for Cretostimogene in Bladder Cancer Treatment; Shares Rise

CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
CGON

Investor's Business Daily

11 days ago

CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
CGON

GlobeNewswire

13 days ago

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
CGON

GlobeNewswire

15 days ago

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025

CGON

MT Newswires

23 days ago

Scotiabank Initiates CG Oncology at Sector Perform With $23 Price Target

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs
CGON

The Wall Street Journal

a month ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade
CGON

Zacks

a month ago

Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
CGON

GlobeNewswire

a month ago

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates

Company News for Mar 31, 2025
CGON

Zacks

a month ago

Company News for Mar 31, 2025

CGON

MT Newswires

a month ago

CG Oncology Files Mixed Shelf

CG Oncology Full Year 2024 Earnings: Misses Expectations
CGON

Simply Wall St.

a month ago

CG Oncology Full Year 2024 Earnings: Misses Expectations

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
CGON

GlobeNewswire

a month ago

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates

Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025?
CGON

Insider Monkey

a month ago

Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025?

CGON

MT Newswires

a month ago

CG Oncology Shares Rise After Reporting Bladder Cancer Drug Durability in Phase 3 Trial

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
CGON

GlobeNewswire

2 months ago

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
CGON

GlobeNewswire

2 months ago

CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
CGON

GlobeNewswire

2 months ago

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now?
CGON

Insider Monkey

2 months ago

Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now?

Why CG Oncology, Inc. (CGON) is the Most Oversold Pharma Stock to Buy According to Analysts
CGON

Insider Monkey

3 months ago

Why CG Oncology, Inc. (CGON) is the Most Oversold Pharma Stock to Buy According to Analysts

Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now
CGON

Insider Monkey

3 months ago

Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now

CG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62%
CGON

Simply Wall St.

3 months ago

CG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62%

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
CGON

Zacks

3 months ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect?
CGON

Zacks

4 months ago

Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect?

CGON

MT Newswires

4 months ago

TD Cowen Initiates CG Oncology at Buy

How to Navigate the Stock and Bond Markets in 2025
CGON

The Wall Street Journal

4 months ago

How to Navigate the Stock and Bond Markets in 2025

CGON

MT Newswires

5 months ago

CG Oncology Insider Sold Shares Worth $19,600,000, According to a Recent SEC Filing

CGON

MT Newswires

5 months ago

CG Oncology Closes $238 Million Offering

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CGON

GlobeNewswire

5 months ago

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CGON

MT Newswires

5 months ago

CG Oncology Prices $204.4 Million Public Offering

CG Oncology Announces Pricing of Public Offering
CGON

GlobeNewswire

5 months ago

CG Oncology Announces Pricing of Public Offering

CGON

MT Newswires

5 months ago

CG Oncology Files for Proposed Public Share Offering

CG Oncology Announces Proposed Public Offering
CGON

GlobeNewswire

5 months ago

CG Oncology Announces Proposed Public Offering

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
CGON

GlobeNewswire

5 months ago

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CG Oncology announces data from Phase 3 BOND-003 trial
CGON

TipRanks

5 months ago

CG Oncology announces data from Phase 3 BOND-003 trial

CGON

MT Newswires

5 months ago

CG Oncology Reports 74.5% Complete Response in Study of Bladder Cancer Candidate

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate
CGON

Benzinga

5 months ago

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CGON

GlobeNewswire

5 months ago

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024
CGON

GlobeNewswire

5 months ago

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting
CGON

GlobeNewswire

6 months ago

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting

CG Oncology Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
CGON

Simply Wall St.

6 months ago

CG Oncology Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

CGON

MT Newswires

6 months ago

CG Oncology's Q3 Loss Narrows

CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
CGON

GlobeNewswire

6 months ago

CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates

CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer
CGON

GlobeNewswire

6 months ago

CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer

CGON

MT Newswires

6 months ago

UBS Initiates CG Oncology With Buy Rating, $60 Price Target

We Think CG Oncology (NASDAQ:CGON) Can Afford To Drive Business Growth
CGON

Simply Wall St.

7 months ago

We Think CG Oncology (NASDAQ:CGON) Can Afford To Drive Business Growth

CGON

MT Newswires

8 months ago

RBC Initiates CG Oncology at Outperform, Speculative Risk With $66 Price Target

Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock
CGON

Insider Monkey

8 months ago

Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock

CGON

MT Newswires

8 months ago

CG Oncology Insider Sold Shares Worth $23,000,089, According to a Recent SEC Filing

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
CGON

GlobeNewswire

8 months ago

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

CGON

MT Newswires

8 months ago

Roth MKM Initiates CG Oncology at Buy With $65 Price Target

Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock
CGON

Simply Wall St.

9 months ago

Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock

CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates
CGON

GlobeNewswire

9 months ago

CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates

Institutional investors in CG Oncology, Inc. (NASDAQ:CGON) must be dismayed after prices dropped by 13% last week
CGON

Simply Wall St.

9 months ago

Institutional investors in CG Oncology, Inc. (NASDAQ:CGON) must be dismayed after prices dropped by 13% last week

CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
CGON

GlobeNewswire

a year ago

CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
CGON

GlobeNewswire

a year ago

CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC

CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting
CGON

GlobeNewswire

a year ago

CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting

CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
CGON

GlobeNewswire

a year ago

CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CGON

GlobeNewswire

a year ago

Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
CGON

GlobeNewswire

a year ago

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
CGON

GlobeNewswire

a year ago

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
CGON

GlobeNewswire

a year ago

CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting

CGON

GlobeNewswire

a year ago

CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer

MOD vs. RACE: Which Stock Is the Better Value Option?
CGON

Zacks

a year ago

MOD vs. RACE: Which Stock Is the Better Value Option?

Oil: Where prices could be heading after January gains
CGON

Yahoo Finance Video

a year ago

Oil: Where prices could be heading after January gains

UMB (UMBF) Reports Q4 Earnings: What Key Metrics Have to Say
CGON

Zacks

a year ago

UMB (UMBF) Reports Q4 Earnings: What Key Metrics Have to Say

Analysts Estimate PJT Partners (PJT) to Report a Decline in Earnings: What to Look Out for
CGON

Zacks

a year ago

Analysts Estimate PJT Partners (PJT) to Report a Decline in Earnings: What to Look Out for

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CGON

Business Wire

a year ago

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CGON

Business Wire

a year ago

Form 8.3 - DX (Group) plc

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030
CGON

GlobeNewswire

a year ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

In Bad News for IPO Market, BrightSpring Closes Below Offering Price
CGON

The Wall Street Journal

a year ago

In Bad News for IPO Market, BrightSpring Closes Below Offering Price

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day
CGON

Zacks

a year ago

Boston Beer and Huntsman have been highlighted as Zacks Bull and Bear of the Day

Tiger Pistol Expands Partnership with The Wendy's Company to Empower Franchisees with TikTok Advertising
CGON

PR Newswire

a year ago

Tiger Pistol Expands Partnership with The Wendy's Company to Empower Franchisees with TikTok Advertising

CG Oncology Announces Pricing of Upsized Initial Public Offering
CGON

Business Wire

a year ago

CG Oncology Announces Pricing of Upsized Initial Public Offering

Sportradar Announces Additional Strategic Actions to Streamline Organizational Structure and Drive Growth and Innovation
CGON

GlobeNewswire

a year ago

Sportradar Announces Additional Strategic Actions to Streamline Organizational Structure and Drive Growth and Innovation

Sensata Technologies Holding's (NYSE:ST) Returns On Capital Not Reflecting Well On The Business
CGON

Simply Wall St.

a year ago

Sensata Technologies Holding's (NYSE:ST) Returns On Capital Not Reflecting Well On The Business

3 Wireless Stocks Set to Sail Against the Ailing Industry
CGON

Zacks

a year ago

3 Wireless Stocks Set to Sail Against the Ailing Industry

Q3 Earnings Outperformers: Varonis (NASDAQ:VRNS) And The Rest Of The Cybersecurity Stocks
CGON

StockStory

a year ago

Q3 Earnings Outperformers: Varonis (NASDAQ:VRNS) And The Rest Of The Cybersecurity Stocks

2024 Will Be the Year of AI. 2 Top Stocks I Expect to Surge.
CGON

Motley Fool

a year ago

2024 Will Be the Year of AI. 2 Top Stocks I Expect to Surge.

Q3 Rundown: Freshworks (NASDAQ:FRSH) Vs Other Sales Software Stocks
CGON

StockStory

a year ago

Q3 Rundown: Freshworks (NASDAQ:FRSH) Vs Other Sales Software Stocks

Sprinklr Appoints Trac Pham New Interim Chief Operating Officer, Authorizes $100 Million Stock Buyback Program, and Reaffirms Financial Guidance for Q4 and Full Year FY 2024
CGON

Business Wire

a year ago

Sprinklr Appoints Trac Pham New Interim Chief Operating Officer, Authorizes $100 Million Stock Buyback Program, and Reaffirms Financial Guidance for Q4 and Full Year FY 2024

Why Asana (ASAN) Stock Might be a Great Pick
CGON

Zacks

a year ago

Why Asana (ASAN) Stock Might be a Great Pick

Dycom Industries, Inc.'s (NYSE:DY) 32% Price Boost Is Out Of Tune With Earnings
CGON

Simply Wall St.

a year ago

Dycom Industries, Inc.'s (NYSE:DY) 32% Price Boost Is Out Of Tune With Earnings

CGON

PR Newswire

a year ago

Autohome Inc. Announces CEO and Board Changes

CGON

PR Newswire

a year ago

Autohome Inc. Announces Cash Dividend and Amendment to Dividend Policy

Royce Investment Partners Commentary: Can 2 Small-Cap Aviation Holdings Fly Higher?
CGON

GuruFocus.com

a year ago

Royce Investment Partners Commentary: Can 2 Small-Cap Aviation Holdings Fly Higher?

Some BRP Inc. (TSE:DOO) Analysts Just Made A Major Cut To Next Year's Estimates
CGON

Simply Wall St.

a year ago

Some BRP Inc. (TSE:DOO) Analysts Just Made A Major Cut To Next Year's Estimates

Be Wary Of Autohome (NYSE:ATHM) And Its Returns On Capital
CGON

Simply Wall St.

a year ago

Be Wary Of Autohome (NYSE:ATHM) And Its Returns On Capital

Insiders hold 82% of Summit Therapeutics Inc. (NASDAQ:SMMT), and they've been buying recently
CGON

Simply Wall St.

a year ago

Insiders hold 82% of Summit Therapeutics Inc. (NASDAQ:SMMT), and they've been buying recently

LCI Industries (NYSE:LCII) Has Affirmed Its Dividend Of $1.05
CGON

Simply Wall St.

a year ago

LCI Industries (NYSE:LCII) Has Affirmed Its Dividend Of $1.05

Analysts' Revenue Estimates For Crescent Point Energy Corp. (TSE:CPG) Are Surging Higher
CGON

Simply Wall St.

a year ago

Analysts' Revenue Estimates For Crescent Point Energy Corp. (TSE:CPG) Are Surging Higher

Share on Social Networks: